Notice: This company has been marked as potentially delisted and may not be actively trading. Catalent (CTLT) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Get the Latest News and Ratings for CTLT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Catalent and its competitors. Enter your email to sign up for newsletter Sign Up CTLT Analyst Ratings Over TimeTypeCurrent Forecast2/6/24 to 2/5/251 Month Ago1/7/24 to 1/6/253 Months Ago11/8/23 to 11/7/241 Year Ago2/6/23 to 2/6/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)3 Buy rating(s)Hold7 Hold rating(s)7 Hold rating(s)8 Hold rating(s)9 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)Consensus Price Target$63.40$63.40$59.83$52.46Forecasted Upside-0.13% Downside-0.13% Downside-0.09% Downside-10.25% DownsideConsensus RatingHoldHoldHoldHold CTLT Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CTLT Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Catalent Stock vs. The CompetitionTypeCatalentMedical CompaniesS&P 500Consensus Rating Score 2.00 2.82 2.53Consensus RatingHoldModerate BuyModerate BuyPredicted Upside-0.13% Downside15,703.86% Upside13.00% UpsideNews Sentiment RatingNeutral NewsSee Recent CTLT NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails9/24/2024Baird R W0 of 5 starsE. ColdwellSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold9/24/2024Robert W. Baird2 of 5 stars Reiterated RatingOutperform ➝ Neutral$63.50 ➝ $63.50+6.31%9/3/2024William Blair1 of 5 stars Reiterated RatingMarket Perform7/11/2024Royal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingSector Perform ➝ Sector Perform$63.50 ➝ $63.50+10.15%6/28/2024BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetEqual Weight ➝ Equal Weight$47.00 ➝ $63.00+11.98%4/4/2024StephensSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingEqual Weight ➝ Equal Weight$63.50+12.09%2/6/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Neutral$58.00 ➝ $63.50+6.15%11/16/2023Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetEqual Weight ➝ Equal Weight$50.00 ➝ $42.00+6.17%9/5/2023ArgusSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeHold ➝ Buy$62.00+23.51%8/31/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetUnderperform ➝ Underperform$39.00 ➝ $46.00-8.20% Get the Latest News and Ratings for CTLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter. 8/30/2023Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$52.00 ➝ $55.00+9.26%8/15/2023Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetHold ➝ Hold$37.00 ➝ $45.00-0.97%6/14/2023Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$45.00 ➝ $44.00+0.34%5/21/2023JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Neutral$90.00 ➝ $45.00+21.07%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:59 AM ET. CTLT Forecast - Frequently Asked Questions What is Catalent's forecast for 2025? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Catalent is $63.40, with a high forecast of $63.50 and a low forecast of $63.00. Should I buy or sell Catalent stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last year. There are currently 7 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CTLT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CTLT, but not buy additional shares or sell existing shares. Does Catalent's stock price have much downside? According to analysts, Catalent's stock has a predicted downside of -0.13% based on their 12-month stock forecasts. Do Wall Street analysts like Catalent more than its competitors? Analysts like Catalent less than other "medical" companies. The consensus rating for Catalent is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CTLT compares to other companies. Stock Forecasts and Research Tools Related Companies ARGX Stock Forecast BNTX Stock Forecast TEVA Stock Forecast BGNE Stock Forecast SMMT Stock Forecast MRNA Stock Forecast ITCI Stock Forecast VTRS Stock Forecast GMAB Stock Forecast RDY Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:CTLT) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
